Abstract:Abstract Epilepsy is a recurring neurological disease caused by the abnormal electrical activity in the brain. This disease has caused about 50 new cases in 100,000 populations every year with the clinical manifestations of awareness loss, bruising, and mobility abnormalities. Due to the lack understanding of the pathophysiology behind the illness, a wide variety of medications are available to treat epilepsy. Epileptogenesis is the process by which a normally functioning brain undergoes alterations leading to the development of epilepsy, involving various factors. This is related to the inflammation which is driven by cytokines like IL-1 and tumor necrosis factor-α (TNF-α) leads to neuronal hyperexcitability. Pro-inflammatory cytokines from activated microglia and astrocytes in epileptic tissue initiate an inflammatory cascade, heightening neuronal excitability and triggering epileptiform activity. The blood-brain barrier (BBB) maintains central nervous system integrity through its tight endothelial connections, but inflammation impact BBB structure and function which leads to immune cell infiltration. The mammalian target of rapamycin (mTOR) pathway’s excessive activation influences epileptogenesis, impacting neuronal excitability, and synapse formation, with genetic mutations contributing to epilepsy syndromes and the modulation of autophagy playing a role in seizure onset. The apoptotic pathway contribute to cell death through glutamate receptor-mediated excitotoxicity, involving pro-apoptotic proteins like p53 and mitochondrial dysfunction, leading to the activation of caspases and the disruption of calcium homeostasis. Ionic imbalances within neural networks contribute to the complexity of epileptic seizures, involving alterations in voltage-gated sodium and potassium channels, and the formation of diverse ion channel subtypes. Epileptogenesis triggers molecular changes in hippocampus, including altered neurogenesis and enhanced expression of neurotrophic factors and proteins. Oxidative stress leads to cellular damage, disrupted antioxidant systems, and mitochondrial dysfunction, making it a key player in epileptogenesis and potential neuroprotective interventions. Thalamocortical circuitry disruption is central to absence epilepsy, the normal circuit becomes faulty and results in characteristic brain wave patterns.

Neuroinflammation in Epileptogenesis: from Pathophysiology to Therapeutic Strategies

Immune mechanisms in epileptogenesis.

Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis

Intestinal Microbiota As an Alternative Therapeutic Target for Epilepsy

The Neurovascular Unit Dysfunction in the Molecular Mechanisms of Epileptogenesis and Targeted Therapy

Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy

Inflammation and prevention of epileptogenesis

Role of Inflammatory Mediators in the Pathogenesis of Epilepsy

Interleukins in Epilepsy: Friend or Foe

[New developments in epileptogenesis and therapeutic perspectives]

Epigenetic regulation in epilepsy: A novel mechanism and therapeutic strategy for epilepsy

The Role of Interleukin-17 in Epilepsy.

Microglia in epilepsy

Research progress in molecular mechanisms of epileptogenesis

Molecular Mechanism Involved in the Pathogenesis of Early-Onset Epileptic Encephalopathy

The role of inflammation in the development of epilepsy

Mechanism of NLRP3 inflammasome in epilepsy and related therapeutic agents

Biomolecular mechanisms of epileptic seizures and epilepsy: a review

Decoding Epileptic Seizures: Exploring In Vitro Approaches to Unravel Pathophysiology and Propel Future Therapeutic Breakthroughs

Advanced Molecular Mechanisms of Epilepsy

Unraveling the Neural Circuits: Techniques, Opportunities and Challenges in Epilepsy Research